Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.84 USD
Change Today +0.08 / 4.55%
Volume 84.7K
ECTE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert F. Doman M.D.

Former Executive Chairman, Echo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 5 different industries.

See Board Relationships
64--
As of Fiscal Year 2013

Background*

Dr. Robert J. Doman, also known as Bob, M.D., serves as the President of The Leach Technology Group. Dr. Doman served as an Interim Chief Executive Officer at Echo Therapeutics, Inc. from August 2013 to July 1, 2014. He served as the Chief Executive Officer of Dusa Pharmaceuticals Inc. since June 14, 2007 and served as its President since January 2005. Dr. Doman has more than 25 years experience in the medical device industry, with domestic and international experience ...

Read Full Background

Corporate Headquarters*

99 Wood Avenue South
Iselin, New Jersey 08830

United States

Phone: 732-549-0919
Fax: --

Board Members Memberships*

2006-2012
Former Chief Executive Officer and President
2013-N/A
Former Executive Chairman
2013-Present
Director, Chairman of Research & Development Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

Bachelor's Degree
Saint Joseph's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECTE:US $1.84 USD +0.08

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECHO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.